Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Ivermectin earned its creators a Nobel Prize in 2015 — then the same establishment that celebrated it tried to bury it. Here's the full story.
In 2016, Joe Tippens was given three months to live with small-cell lung cancer. His recovery with fenbendazole sparked a global research movement.
HCQ has been prescribed safely since 1955. Lupus and rheumatoid arthritis patients have taken it for decades. The 2020 controversy ignored all of this.
Mebendazole — a cheap, widely available antiparasitic — is showing remarkable results in cancer research labs. Here's why it isn't on your oncologist's radar.
The Front Line COVID-19 Critical Care Alliance doctors risked their careers to share early treatment protocols. Here's what they recommended and why.
Millions of Americans are struggling with long-COVID. A growing body of clinical reports and patient experience suggests ivermectin may offer significant relief.
Doxycycline is best known as an antibiotic, but decades of research reveal remarkable anti-inflammatory and potential antiviral properties that go far beyond bacteria.
Albendazole, a widely used antiparasitic, shares a cancer-fighting mechanism with mebendazole and fenbendazole — and the research is quietly growing.
Praziquantel is the gold standard for treating tapeworm and fluke infections — and controlling parasitic burden may be one of the most overlooked aspects of immune optimization.